Anton, you are onto something there for sure
OncoSil Medical Ltd's strategic advancements, including the authorization for 84 German hospitals to negotiate funding, the establishment of a new distribution network in Turkey, the collaboration with Cyclotek at Macquarie University Hospital for a strengthened global supply, and the PANCOSIL trial that tests the transition to a CT-guided percutaneous radionuclide therapy application method, collectively enhance its global market stance.
These developments not only expand market access in key regions but also improve the delivery and accessibility of the OncoSilTM device, positioning OncoSil Medical to effectively meet the rising global demand for innovative cancer treatments.
This integrated strategy underscores the company's commitment to advancing cancer care and solidifies its standing in the international medical device sector.
…
Anton, you are onto something there for sureOncoSil Medical...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.3¢ | $9.782K | 752.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 11636360 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 4307472 | 9 |
View Market Depth
| Last trade - 14.13pm 02/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |